What's happened
The World Health Organization has designated the new COVID variant NB.1.8.1 as a 'variant under monitoring.' It now accounts for over 10% of global infections, with cases confirmed in Northern Ireland and Wales. While it spreads more easily, there is no evidence it causes more severe illness compared to previous variants.
What's behind the headline?
Key Insights
- Transmission Dynamics: NB.1.8.1 shows a growth advantage, indicating it spreads more efficiently than earlier variants. This could lead to increased case numbers, especially in regions with low vaccination rates.
- Symptoms and Severity: Current data suggests that while NB.1.8.1 may cause gastrointestinal symptoms, it does not lead to more severe illness than previous strains. This is crucial for public health messaging.
- Vaccine Efficacy: Current COVID-19 vaccines are expected to remain effective against this variant, which is a positive sign for ongoing vaccination efforts.
- Public Health Implications: As testing rates decline, accurately tracking the spread of NB.1.8.1 becomes challenging. Public health agencies must adapt strategies to monitor and respond to this evolving situation.
What the papers say
According to The Independent, NB.1.8.1 accounts for over 10% of global infections and has been confirmed in Northern Ireland and Wales. Experts note that while it spreads more easily, it does not appear to cause more severe symptoms. The WHO has classified it as a 'variant under monitoring' due to its rapid spread and potential implications for public health. SBS highlights that genomic sequencing in Australia shows NB.1.8.1 is increasing, with wastewater surveillance indicating it is now the dominant variant in Perth. This variant's mutations may enhance its ability to infect cells, raising concerns about its transmissibility. Overall, the consensus among experts is that while NB.1.8.1 is more transmissible, it does not lead to more severe illness compared to previous variants.
How we got here
NB.1.8.1, a sublineage of the Omicron variant, was first detected in January 2025. It has rapidly spread globally, particularly in Asia, and is now the dominant variant in several regions, including Hong Kong and China. The WHO's monitoring reflects its increasing prevalence.
Go deeper
- What symptoms are associated with the NB.1.8.1 variant?
- How effective are current vaccines against this new variant?
- What measures are being taken to monitor the spread of NB.1.8.1?
Common question
-
What is the new COVID variant NB.1.8.1 and what should you know?
The emergence of the new COVID variant NB.1.8.1 has raised questions about its impact on public health. As it spreads rapidly across the globe, understanding its characteristics and implications is crucial. Below are some common questions people have regarding this variant and what precautions to take.
More on these topics
-
The World Health Organization is a specialized agency of the United Nations responsible for international public health. The WHO Constitution, which establishes the agency's governing structure and principles, states its main objective as "the attainment
-
The COVID-19 pandemic, also known as the coronavirus pandemic, is an ongoing pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. It was first identified in December 2019 in Wuhan, China.